LenioBio Overview
- Year Founded
-
2016
- Status
-
Private
- Employees
-
45
- Latest Deal Type
-
Grant
- Latest Deal Amount
-
$2.57M
- Investors
-
11
LenioBio General Information
Description
Developer of a synthetic biology and protein expression technology designed to accelerate and simplify protein expression for complex and novel proteins. The company offers a cell-free eukaryotic expression system compatible with linear deoxyribonucleic acid (DNA) and artificial intelligence-designed proteins, enabling biotech and pharmaceutical researchers to access post-translationally modified proteins without relying on cloning or cell lines.
Contact Information
Website
www.leniobio.comCorporate Office
- Erkrather Straße 401
- 40231 Dusseldorf
- Germany
Corporate Office
- Erkrather Straße 401
- 40231 Dusseldorf
- Germany
LenioBio Timeline
LenioBio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 12. Grant | 01-Jun-2026 | $2.57M | Completed | Generating Revenue | ||
| 11. Later Stage VC | 15-Jul-2025 | Completed | Generating Revenue | |||
| 10. Grant | 01-Jul-2025 | Completed | Generating Revenue | |||
| 9. Later Stage VC (Series B) | 13-May-2024 | Completed | Generating Revenue | |||
| 8. Later Stage VC | 31-Jul-2023 | Completed | Generating Revenue | |||
| 7. Grant | 01-Feb-2023 | Completed | Generating Revenue | |||
| 6. Grant | 01-Apr-2022 | Completed | Generating Revenue | |||
| 5. Later Stage VC (Series A) | 18-Feb-2022 | Completed | Generating Revenue | |||
| 4. Accelerator/Incubator | 09-Oct-2020 | $4.48M | Completed | Generating Revenue | ||
| 3. Grant | 23-Aug-2019 | $2.64M | $4.48M | Completed | Generating Revenue |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
LenioBio Comparisons
Industry
Financing
Details
LenioBio Competitors (3)
One of LenioBio’s 3 competitors is New England Biolabs, a Corporation company based in Ipswich, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| New England Biolabs | Corporation | Ipswich, MA | ||||
| Sutro Biopharma | Formerly VC-backed | South San Francisco, CA | ||||
| Ginkgo Bioworks | Formerly VC-backed | Boston, MA |
LenioBio Patents
LenioBio Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2025176699-A1 | A system and method for cell-free unnatural amino acid incorporation | Pending | 20-Feb-2024 | ||
| EP-4527938-A1 | Method for cell-free polypeptide synthesis | Inactive | 22-Sep-2023 | ||
| EP-4780977-A1 | Method for cell-free polypeptide synthesis | Pending | 22-Sep-2023 | ||
| WO-2025061737-A1 | Method for cell-free polypeptide synthesis | Inactive | 22-Sep-2023 | ||
| DE-102023115905-A1 | Controllable disruption of eukaryotic protoplasts to release intact cell organelles | Pending | 20-Jun-2022 | C12M45/02 |
LenioBio Signals
LenioBio Investors (11)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| European Defence Agency | Government | |||
| Coalition for Epidemic Preparedness Innovations | Impact Investing | |||
| European Health and Digital Executive Agency (HaDEA) | Corporation | |||
| German Aerospace Center | Corporation | |||
| Bundesministerium für Bildung und Forschung | Government |
LenioBio FAQs
-
When was LenioBio founded?
LenioBio was founded in 2016.
-
Where is LenioBio headquartered?
LenioBio is headquartered in Dusseldorf, Germany.
-
What is the size of LenioBio?
LenioBio has 45 total employees.
-
What industry is LenioBio in?
LenioBio’s primary industry is Drug Discovery.
-
Is LenioBio a private or public company?
LenioBio is a Private company.
-
What is LenioBio’s current revenue?
The current revenue for LenioBio is .
-
How much funding has LenioBio raised over time?
LenioBio has raised $51.9M.
-
Who are LenioBio’s investors?
European Defence Agency, Coalition for Epidemic Preparedness Innovations, European Health and Digital Executive Agency (HaDEA), German Aerospace Center, and Bundesministerium für Bildung und Forschung are 5 of 11 investors who have invested in LenioBio.
-
Who are LenioBio’s competitors?
New England Biolabs, Sutro Biopharma, and Ginkgo Bioworks are competitors of LenioBio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process